Cambridge
Cambridge ECMC aims to develop molecular prognostic and diagnostic tests to aid treatment decisions. The Centre focuses on genetic predisposition to cancer and the identification of high risk groups. This is being achieved by building on local strengths in genomics, pharmacogenetics, molecular pathology, molecular imaging, clinical informatics and computational biology.
Research Areas
Focus
Molecular pathology, bioinformatics, clinical genomics, molecular imaging, early phase and translational trials
Disease areas
Breast cancer, ovarian cancer, oesophageal adenocarcinoma, pancreatic cancer, prostate cancer, bladder cancer, renal cancer, brain tumours, haematological malignancies
Goals
Skills
Cambridge ECMC principal investigators and staff have a range of skills and expertise.
Facilities
Cambridge ECMC has access to a range of research facilities that are utilised in studies.
Achievements
To learn more about the scientific and operational achievements of Cambridge ECMC go to:
Centre lead
Professor Carlos Caldas
Functional Breast Cancer Genomics Laboratory
Cancer Research UK Cambridge Research Institute
Li Ka-Shing Centre
Robinson Way
Cambridge
CB2 0RE
Tel: +44 (0)1223 404 193
General and Patient Enquiries
Marion Karniely
Tel: +44 (0) 1223 404 179
Clinical Trials Enquiries
You can also find out about trials recruiting in Cambridge on the CancerHelp UK clinical trials database.
Increase text
Decrease text
Print this page